Waver Research

Waver Research

Stock Spotlight

VERISK ANALYTICS (VRSK): The plumbing of insurance

Waver's avatar
Waver
Feb 27, 2026
∙ Paid

0. THE STORY

The Genesis: Verisk is the company that tells insurance companies whether you’re a good driver, if your house will flood, and how much they should charge you. They’ve been collecting data on risk for 50+ years—everything from crime rates to weather patterns to building codes. Insurance companies literally cannot function without this data. It’s the ultimate B2B SaaS business that nobody outside the industry knows exists.

The Current Drama: The stock has been on a tear, up significantly from its 2022 lows and now trading near all-time highs at $210. The market is pricing in perfection: 30x earnings, premium valuation, betting that double-digit growth continues forever. Meanwhile, three concerns are brewing:

  • Can they maintain 12%+ organic growth as the insurance market matures?

  • Will rising interest rates make this high multiple unsustainable?

  • Could AI actually disrupt their 50-year data advantage?

The business is still crushing it—86% subscription revenue, 45% margins—but you’re paying TOP DOLLAR for it.

Why This Matters: This is a textbook “quality at any price?” situation. The moat is undeniable, but at 30x earnings, one stumble and this gets re-priced violently. The question: Is this a compounder worth paying up for, or should you wait for Mr. Market to offer a discount? Let’s dig in.


1. THE MACHINE

The Simple Explanation

Imagine you’re an insurance company and someone applies for car insurance. You need to know: Is this person going to crash? Will they file a claim? How much should I charge them?

You don’t have time to investigate every applicant yourself, so you subscribe to Verisk. They have 50+ years of historical claims data, predictive models, and real-time inputs (DMV records, credit scores, property data). You plug in the applicant’s info, Verisk spits out a risk score in milliseconds, and you price accordingly.

The Beautiful Part: Every insurance company uses Verisk. The more claims data they feed into the system, the better Verisk’s models get. It’s a data flywheel—and you can’t replicate 50 years of proprietary data overnight.

They also sell “decision-making software” (underwriting tools, fraud detection, catastrophe modeling). Once an insurer integrates this into their core workflow, ripping it out would be like replacing your company’s entire nervous system. Nobody does that.

The Moat

Why is this hard to kill?

  1. Data Network Effects: The more insurers use Verisk, the more data flows in → better models → more insurers want to use it. Classic flywheel.

  2. Switching Costs from Hell: Insurance companies have Verisk’s tools embedded in their underwriting, claims processing, and pricing systems. Switching would mean retraining thousands of employees, migrating decades of historical data, and risking regulatory non-compliance. The ROI on switching? Negative.

  3. Regulatory Moat: Insurance is one of the most regulated industries on Earth. Verisk’s data has been vetted by regulators for decades. A new competitor would need years of validation before insurers could even consider them.

  4. Scale Advantages: Verisk covers 90% of the U.S. property & casualty insurance market. Their cost to serve each additional customer is near zero (software scales), while competitors would need massive upfront investment to build comparable datasets.

The ROIC Story

Verisk doesn’t disclose ROIC directly, but we can reverse-engineer it:

  • Operating Margins: ~45% (insane for a data business)

  • Capital Intensity: Low—this is software, not factories. CapEx is ~3-5% of revenue.

  • Estimated ROIC: ~25-30% (back-of-napkin: $1.2B NOPAT / ~$4.5B invested capital)

Can it reinvest? Yes and no. Organic growth is 10-12% annually, but they can’t reinvest all their cash at 25% returns (the insurance market only grows so fast). So they return cash via:

  • Buybacks: $800M-$1B annually (reducing share count ~2.5-3% per year)

  • Acquisitions: Buying adjacent data/analytics businesses to expand the moat

This is a “Compounder + Cannibal” hybrid—grow the core, shrink the share count.

The Risks

What could blow this up?

  1. Valuation Risk (THE BIG ONE): At 30x P/E, you’re paying premium prices. If growth slows from 12% to 8%, or if interest rates stay high, this could re-rate to 22-25x fast. That’s a 20-30% drawdown even if the business is fine.

  2. AI Disruption: Could a well-funded startup use AI to build better risk models faster/cheaper? Maybe. But Verisk is also investing heavily in AI—and they have the data advantage. Hard to out-model someone with 50 years of proprietary training data.

  3. Insurance Market Slowdown: If insurance premiums stop growing (deflation, regulation, competition), Verisk’s pricing power weakens. Right now, the opposite is happening—premiums are rising due to climate risk. But this could reverse.

  4. Regulatory Risk: If regulators crack down on data usage (privacy laws, algorithmic bias concerns), Verisk could face headwinds. Low probability, but worth monitoring.

  5. Customer Concentration: Top 10 customers = ~30% of revenue. Losing one big insurer would sting (though unlikely given switching costs).

  6. The “Quality Trap”: Sometimes the market pays so much for quality that even perfect execution yields mediocre returns. You need growth to ACCELERATE for this valuation to make sense.


2. THE NUMBERS

Current Valuation

  • Price: $210

  • Market Cap: ~$31B

  • Enterprise Value: ~$39B (includes ~$8B debt)

Profitability Snapshot

  • Revenue (TTM): ~$2.7B

  • EPS (TTM): $6.94

  • Net Income (TTM): ~$1.02B

  • Operating Margin: 45% (best-in-class for data analytics)

  • Free Cash Flow: ~$1.1B (CFO - CapEx)

    • FCF Margin: 40%+ (they print cash)

Valuation Metrics

  • P/E Ratio: 30x ($210 / $6.94 = you pay $30 for every $1 of earnings)

  • Historical P/E Range (5Y): 20x - 35x | Avg: ~28x

  • Earnings Yield: 3.3% (= 1 / 30)

    • vs 10Y US Treasury: ~4.5%

    • vs S&P 500 Earnings Yield: ~4%

Interpretation: This is a red flag. Verisk’s earnings yield (3.3%) is BELOW the risk-free rate (4.5%). You’re earning less than Treasury bonds while taking equity risk. The market is pricing in significant growth—you’re paying for future earnings, not current cash flow. If that growth doesn’t materialize, you’re underwater even if the business is fine.

Shareholder Returns

  • Dividend Yield: 0.7% (token dividend, not the focus)

  • Buyback Yield: ~2.5-3% ($800M-$1B buybacks / $31B market cap)

  • Total Shareholder Yield: ~3.2-3.7%

Consistent, but not spectacular. They’re shrinking the share count steadily.

Quality Indicators

  • Debt/EBITDA: ~3.5x (manageable, not alarming)

  • Interest Coverage: ~12x (EBIT / Interest Expense—no stress here)

  • Revenue Retention: 95%+ (customers don’t leave)


3. THE NAPKIN MATH (5-Year Forward Return Projection)

The Waver Return Formula:

Expected Annual Return= (EPS Growth) + (Shareholder Yield) ± (Multiple Change)


A. Growth Driver (EPS Growth Estimate)

Revenue Growth:

  • Organic growth: ~10-12% (insurance premiums rising, data upsells, new products)

  • Acquisitions: ~2-3% (bolt-on deals)

  • Total Top-Line Growth: ~12-15% annually

Margin Story:

  • Operating margins already at 45%—limited expansion room

  • Assume flat to +50bps over 5 years (cost discipline, scale)

Share Buybacks:

  • Repurchasing ~2.5-3% of shares annually at current pace

  • Assuming $900M/year buybacks, share count drops 12-15% over 5 years

Total EPS Growth Estimate:

  • Revenue: +12%

  • Buybacks: +2.5%

  • Margin expansion: +0.5%

  • Total: ~14-15% EPS growth annually


B. Shareholder Yield

  • Dividend: 0.7%

  • Buybacks: 2.5%

  • Total: 3.2%


C. The Valuation Drag/Boost (Our CRITICAL Variable)

Current P/E: 30x
Historical Average P/E (5Y): 28x
Conservative Reversion Target: 25x (midpoint of historical range, sustainable premium)

Why 25x and not 28x or 30x?

  • At 30x, you’re at the high end of the historical range

  • Rising interest rates make high multiples harder to justify (higher discount rates)

  • 25x is still a premium multiple (reflects quality moat), but more sustainable long-term

  • Even high-quality compounders eventually mean-revert on valuation

The Math:

  • If P/E compresses from 30x → 25x over 5 years

  • Annual drag: (25/30)^(1/5) - 1 = -3.5% per year

This is the KEY risk. You could have a perfect business execution and still lose money if the multiple compresses.


D. The Final Equation (BASE CASE)

Total Expected Return =15% + 3.2% − 3.5% = 14.7% Annual Return

Contextualize:

  • vs S&P 500 (~10% historical): Verisk wins by 4.7 percentage points

  • vs Risk-Free Rate (~4.5%): You’re getting a 10% premium for equity risk

  • vs High-Quality Compounders (15%+ bogey): Verisk just barely clears the bar

The Verdict: This is a solid but not spectacular return for the risk you’re taking.


THE BEAR CASE (P/E compresses to 22x - Growth Slowdown Scenario)

If organic growth slows to 8% OR interest rates stay elevated:

  • Multiple drag: (22/30)^(1/5) - 1 = -6.1% per year

  • Total Return: 15% + 3.2% - 6.1% = ~12% annually

Still beats the S&P, but you’re taking single-stock concentration risk for a 2% premium. Not compelling.


THE BULL CASE (P/E stays at 30x - Perfect Execution)

If Verisk maintains its premium multiple (growth accelerates to 15%+, rates drop, AI fears dissipate):

  • Multiple change: 0%

  • Total Return: 15% + 3.2% + 0% = ~18% annually

This requires everything to go RIGHT. Possible, but you’re not getting paid for the downside risk.


PROBABILITY - WEIGHTED RETURN

Good, but not great given the valuation risk.


4. MY PROPRIETARY INSIGHT

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2026 Waver · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture